NLJ: Ninth Circuit Considers Limits to DEA Access to Oregon Prescription Drug Monitoring Program

NLJ: Ninth Circuit Considers Limits to DEA Access to Oregon Prescription Drug Monitoring Program:

On November 7, 2016, the US Court of Appeals for the Ninth Circuit heard arguments in Oregon Prescription Drug Monitoring Program v. United States DEA, No. 14-35402 (9th Cir. 2016). Here, the Drug Enforcement Administration (DEA) sought to overturn a ruling that the DEA’s use of administrative subpoenas to access records from the Prescription Drug Monitoring Program (PDMP) violates the Fourth Amendment, resulting in potentially wide-ranging implications.

This entry was posted in Reasonable expectation of privacy. Bookmark the permalink.

Comments are closed.